Aliment Capital

Aliment Capital Overview

Pontifax Agtech is a pioneering growth equity investor in food and agriculture technology. The firm invests globally in businesses that improve agricultural productivity, sustainability, and supply chain efficiency. Pontifax Agtech has a strong, proprietary ecosystem of technical advisors and global strategic partners, which facilitates its ability to deeply understand technology and to transform emerging agtech companies into profitable, well-positioned market leaders. Pontifax Agtech is the fourth fund of Pontifax, Israels leading life sciences investment firm. Pontifax was founded, capitalized, and chaired by Eli Hurvitz, founder and longtime CEO of Teva Pharmaceuticals. The fund has proprietary market position in Israel and the U.S. (California), two of the worlds leading centers of innovation.

Latest News

Oct 8, 2020 · www.finsmes.com

growth-positive

Pontifax AgTech Closes $302M Food and Agriculture Technology Fund

Pontifax AgTech Management has closed its second fund, Pontifax Global Food and Agriculture Technology Fund II, with commitments totaling $302m. The fund received commitments from institutional investors, including financial institutions, state pension funds, university endowments, foundations, investment firms, large-scale growers, and family offices. Pontifax AgTech invests globally in established businesses with proven technologies that improve the productivity, sustainability, and efficiency of the food and agriculture supply chain. The funds inaugural investment was in Provivi, a company that develops biological crop protection technology. Pontifax AgTechs first fund, closed in October 2017, has already monetized two investments through the sale of Blue River Technology and the IPO of Precision Biosciences.

Investment

Oct 10, 2017 · agfundernews.com

growth-positive

Pontifax AgTech Closes Fund I on $105m - AFN

Pontifax AgTech has closed its first fund on $105 million, raising capital predominantly from institutional investors. The growth equity fund aims to make up to 10 investments in total, investing around $5 million in each company initially, with a further $10 million to $15 million for follow-on funding. The fund has already exited Blue River, which it invested in at Series B stage, acquired by John Deere for $305 million last month. Pontifax AgTech is partnered with Pontifax, a global life sciences venture capital investor based in Israel. The fund is interested in life sciences, labor and supply chain efficiency, and revolutionizing the post-harvest supply chain. Aquaculture, animal health, and vertical farming are also areas of interest. The founders believe there is a strong intersection between human health and agriculture.

Investment

Mar 9, 2016 · agfundernews.com

growth-positive

PE Magnates Take Pontifax to First Close on New Breed of Agtech Fund - exclusive - AFN

Pontifax AgTech, an agtech fund, has raised $200 million in a private equity vehicle. The fund focuses on later stage deals and engages strategic players in its investments. Its founding investors include high-profile individuals such as David Bonderman, Tony Ressler, Haim Saban, and Stewart Resnick. The fund has made four investments prior to its formation, which have now been rolled into the fund. Pontifax AgTech aims to solve key problems in the agriculture supply chain through its investments. The fund plans to collaborate with leading global ag companies and attract co-investment from them. Pontifax AgTech is the first dedicated agtech fund for Pontifax, a global life sciences venture capital investor based in Israel.

Investment

Feb 2, 2016 · news.nocamels.com

growth-positive

Pontifax Raises $50M For Its AgriTech Fund

Israeli life sciences venture capital firm Pontifax has raised $50 million for its first fund in food and agriculture technologies. Pontifax specializes in pharmaceutical, biotech, and medical devices investments. The firm currently manages $445 million in four funds and has invested in over 40 companies. Two of its portfolio companies, ReWalk and CCAM Biotherapeutics, have recently exited. ReWalk now trades on the Nasdaq with a market cap of $125.17 million, while CCAM Biotherapeutics was acquired by Merck. Pontifaxs first two funds have achieved impressive annual returns of 48% and 31% respectively.

InvestmentAcquisition

Sep 14, 2015 · news.nocamels.com

growth-positive

Report: Pontifax Raising $100M AgTech Fund

Israeli venture capital firm Pontifax is seeking to raise $100 million for the creation of a new fund, Pontifax AgTech, which will invest in agricultural technology and food technology startups in Israel and the United States. The financing for the fund is expected to close in March 2016.

Investment

Team Members

3

Web & Social Links

Locations

Tel Aviv-Yafo, Israel

Photos & Videos

No files yet

Aliment Capital Internal

Recent Updates

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info